Pancreatic enzymes in the focus of therapy: contemporary strategies for managing exocrine pancreatic insufficiency
DOI:
https://doi.org/10.15574/SP.2025.9(149).6375Keywords:
exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy, pancreatin, cystic fibrosis, chronic pancreatitis, fecal elastase, children, enzyme preparationsAbstract
Exocrine pancreatic insufficiency (EPI) is a common clinical condition in both children and adults, characterized by malabsorption, nutritional deficiencies, and reduced quality of life.
The aim - to review modern approaches to diagnosis and enzyme replacement therapy for EPI.
In pediatric practice, the leading causes of EPI include cystic fibrosis, chronic pancreatitis, congenital genetic syndromes, celiac disease, and postoperative conditions involving the gastrointestinal tract. Early diagnosis is based on clinical symptoms, laboratory markers (particularly fecal elastase-1), and comprehensive nutritional assessment.
Pancreatic enzyme replacement therapy (PERT) remains the cornerstone of EPI management. Its effectiveness depends on individualized dosing, timing of enzyme intake, and appropriate dietary support. In cases of persistent symptoms despite PERT, it is essential to evaluate dosage adequacy, administration regimen, and the presence of comorbid gastrointestinal disorders.
This article summarizes current European and North American guidelines on PERT use in children, offering practical recommendations for clinicians.
No conflict of interest was declared by the authors.
References
Austin KM, Gupta ML, Coats SA et al. (2008). Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. The Journal of Clinical Investigation. 118: 1511-1518. https://doi.org/10.1172/JCI33764; PMid:18324336 PMCid:PMC2263145
Barreto SG, Carati CJ, Toouli J, Saccone GTP. (2010). The islet-acinar axis of the pancreas: more than just insulin. Am J Physiol Gastrointest Liver Physiol. 299: G10-22. https://doi.org/10.1152/ajpgi.00077.2010; PMid:20395539
Beharry S, Ellis L, Corey M, Marcon M, Durie P. (2002). How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr. 141: 84-90. https://doi.org/10.1067/mpd.2002.124829; PMid:12091856
Berry AJ. (2014). Pancreatic enzyme replacement therapy during pancreatic insufficiency. Nutr Clin Pract. 29: 312-321. https://doi.org/10.1177/0884533614527773; PMid:24687867
Bodewes FAJA, Verkade HJ, Taminiau JAJM, Borowitz D, Wilschanski M. (2015). Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation. J Cyst Fibros. 14: 169-177. https://doi.org/10.1016/j.jcf.2015.01.006; PMid:25677689
Borowitz D, Robinson KA, Rosenfeld M et al. (2009). Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 155(6): S73-S93. https://doi.org/10.1016/j.jpeds.2009.09.001; PMid:19914445 PMCid:PMC6324931
Borowitz SF, Gelfond D, Maguiness K et al. (2015). Maximizing absorption of fat-soluble vitamins in patients with cystic fibrosis: Best practices and practical considerations with a focus on patients with pancreatic insufficiency. J Acad Nutr Diet. 115(5): 781-789.
Conwell DL, Banks PA, Sandberg AA et al. (2009). American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: Evidence-Based Report on Diagnostic Guidelines. Pancreas. 38(8): 1058-1067.
Cruz LA, Parniczky A, Mayhew A et al. (2017). Utility of direct pancreatic function testing in children. Pancreas. 46(2): 177-182. https://doi.org/10.1097/MPA.0000000000000724; PMid:27846137
Domínguez-Muñoz JE. (2011). Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it? Adv Med Sci. 56: 1-5. https://doi.org/10.2478/v10039-011-0005-3; PMid:21450558
Dominguez-Muñoz JE, Nieto L, Vilarino M et al. (2018). Effects of oral pancreatic enzyme substitution on nutritional status and quality of life in patients with chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 18(2): 221-228.
Domínguez-Muñoz JE, Nieto L, Vilariño M, Lourido MV, Iglesias-García J. (2016). Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas. 45(2): 241-247. https://doi.org/10.1097/MPA.0000000000000434; PMid:26390420
Fieker A, Philpott J, Armand M. (2011). Enzyme replacement therapy for pancreatic insufficiency: Present and future. Clin Exp Gastroenterol. 4: 55-73. https://doi.org/10.2147/CEG.S17634; PMid:21753892 PMCid:PMC3132852
Food and Drug Administration. (2012). Updated questions and answers for healthcare professionals and the public: use an approved pancreatic enzyme product (PEP). URL: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm204745.htm. Accessed 24 Aug 2016.
Freeman AJ, Maqbool A, Bellin MD, Goldschneider KR, Grover AS, Hartzell C et al. (2021, Feb 1). Medical Management of Chronic Pancreatitis in Children: A Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee. J Pediatr Gastroenterol Nutr. 72(2): 324-340. https://doi.org/10.1097/MPG.0000000000003001; PMid:33230082 PMCid:PMC8054312
Frulloni L, Falconi M, Gabbrielli A, Gaia E, Graziani R, Pezzilli R et al. (2010). Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 42; Suppl 6: S381-406. https://doi.org/10.1016/S1590-8658(10)60682-2; PMid:21078490
Garah J, Rosen I, Shaoul R. (2019, Apr). Transient Exocrine Pancreatic Insufficiency in Children: An Existing Entity? J Pediatr Gastroenterol Nutr. 68(4): 574-577. https://doi.org/10.1097/MPG.0000000000002267; PMid:30633105
Halloran CM, Cox TF, Chauhan S, Raraty MGT, Sutton R et al. (2012). Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: A prospective study. Pancreatology. 11: 535-545. https://doi.org/10.1159/000333308; PMid:22094930
Hopson P, Smadi Y, Mehta V, Patel S, Mehta D, Horvath K. (2022). Assessment of exocrine pancreatic function in children and adolescents with direct and indirect testing. Front Pediatrics. 10: 908542. https://doi.org/10.3389/fped.2022.908542; PMid:36452348 PMCid:PMC9704773
Khan A, Vege SS, Dudeja V, Chari ST. (2022). Staging exocrine pancreatic dysfunction. Pancreatology. 22(1): 168-172. https://doi.org/10.1016/j.pan.2021.11.005; PMid:34916141
Law R, Parsi M, Lopez R, Zuccaro G, Stevens T. (2010). Cigarette smoking is independently associated with chronic pancreatitis. Pancreatology. 10: 54-59. https://doi.org/10.1159/000225927; PMid:20332662
Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. (1994). The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 107: 1481-1487. https://doi.org/10.1016/0016-5085(94)90553-3; PMid:7926511
Lieb J-G. (2008). Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol. 14: 3149. https://doi.org/10.3748/wjg.14.3149; PMid:18506918 PMCid:PMC2712845
Löhr JM, Dominguez-Muñoz E, Rosendahl J et al. (2017). United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 5(2): 153-199. https://doi.org/10.1177/2050640616684695; PMid:28344786 PMCid:PMC5349368
Martin CR, Cheesman A, Brown J, Makda M, Kutner AJ, DaSilva D et al. (2016). Factors determining optimal fatty acid absorption in preterm infants. J Pediatr Gastroenterol Nutr. 62: 130-136. https://doi.org/10.1097/MPG.0000000000000934; PMid:26252920 PMCid:PMC4691401
Martínez J, Abad-González A, Aparicio JR, Aparisi L, Boadas J, Boix E et al. (2012). The Spanish Pancreatic Club recommendations for the diagnosis and treatment of chronic pancreatitis: Part 1 (diagnosis). Pancreatology. 13: 18-28. https://doi.org/10.1016/j.pan.2012.11.309; PMid:23395564
Patel N, Sellers ZM, Grover A et al. (2021). Endoscopic pancreatic function testing (ePFT) in children: a position paper from the NASPGHAN pancreas committee. J Pediatr Gastroenterol Nutr. 72(1): 144-150. https://doi.org/10.1097/MPG.0000000000002931; PMid:32910088
Pezzilli R, Andriulli A, Bassi C et al. (2013). Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian Association for the Study of the Pancreas.World J Gastroenterol. 19(44): 7930-7946. https://doi.org/10.3748/wjg.v19.i44.7930; PMid:24307787 PMCid:PMC3848141
Pezzilli R, Morselli Labate AM, Ceciliato R, Frulloni L, Cavestro GM,Comparato G et al. (2005). Quality of life in patients with chronic pancreatitis. Dig Liver Dis. 37: 181-189. https://doi.org/10.1016/j.dld.2004.10.007; PMid:15888283
Phillips ME. (2015). Pancreatic exocrine insufficiency following pancreatic resection. Pancreatology. 15: 449-455. https://doi.org/10.1016/j.pan.2015.06.003; PMid:26145836
Piciucchi M, Capurso G, Archibugi L, Delle Fave MM, Capasso M, Delle FG. (2015). Exocrine pancreatic insufficiency in diabetic patients: Prevalence, mechanisms, and treatment. Int J Endocrinol. 15: 595-649. https://doi.org/10.1155/2015/595649; PMid:25892991 PMCid:PMC4393909
Rings EH, Minich DM, Vonk RJ, Stellaard F, Fetter WP, Verkade HJ. (2002). Functional development of fat absorption in term and preterm neonates strongly correlates with ability to absorb long-chain fatty acids from intestinal lumen. Pediatr Res. 51(1): 57-63. https://doi.org/10.1203/00006450-200201000-00011; PMid:11756640
Sankararaman S, Schindler T. (2023, Oct). Exocrine Pancreatic Insufficiency in Children - Challenges in Management. Pediatric Health Med Ther. 26; 14: 361-378. https://doi.org/10.2147/PHMT.S402589; PMid:37908317 PMCid:PMC10615098
Singh VK, Schwarzenberg SJ. (2017). Pancreatic insufficiency in cystic fibrosis. J Cystic Fibrosis. 16: S70-S78. https://doi.org/10.1016/j.jcf.2017.06.011; PMid:28986019
Soave D, Miller MR, Keenan K, Li W, Gong J, Ip W et al. (2014). Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis- related diabetes: a Mendelian randomization study. Diabetes. 63: 2114-2119. https://doi.org/10.2337/db13-1464; PMid:24550193 PMCid:PMC4030111
Struyvenberg MR, Martin CR, Freedman SD. (2017, Feb 10). Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med. 15(1): 29. https://doi.org/10.1186/s12916-017-0783-y; PMid:28183317 PMCid:PMC5301368
Trang T, Chan J, Graham DY. (2014). Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century. World J Gastroenterol. 20: 11467-11485. https://doi.org/10.3748/wjg.v20.i33.11467; PMid:25206255 PMCid:PMC4155341
Turck D, Braegger CP, Colombo C et al. (2016). ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutrition. 35(3): 557-577. https://doi.org/10.1016/j.clnu.2016.03.004; PMid:27068495
Vanga RR, Tansel A, Sidiq S, El-Serag HB, Othman MO. (2018). Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 16(8): 1220-1228, e1224. https://doi.org/10.1016/j.cgh.2018.01.027; PMid:29374614 PMCid:PMC6402774
Vege SS, Chari ST. (2006). Chronic pancreatitis: Current concepts in epidemiology, etiology, and pathophysiology. Clin Gastroenterol Hepatol. 4(9): 1013-1027.
Waters DL, Dorney SF, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B. (1990). Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med. 322: 303-308. https://doi.org/10.1056/NEJM199002013220505; PMid:2296272
Wilschanski M, Novak KL, Mascarenhas M et al. (2016). Nutritional and Gastrointestinal Management of Cystic Fibrosis in Childhood: ESPGHAN and NASPGHAN Joint Expert Guidance. J Pediatr Gastroenterol Nutr. 63(2): 158-177.
Witt H, Apte MV, Keim V, Wilson JS. (2007). Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology. 132(4): 1557-1573. https://doi.org/10.1053/j.gastro.2007.03.001; PMid:17466744
Woestenenk JW, van der Ent CK, Houwen RH. (2015). Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis. J Pediatr Gastroenterol Nutr. 61: 355-360. https://doi.org/10.1097/MPG.0000000000000784; PMid:25782658
Working Party of the Australasian Pancreatic C, Smith RC, Smith SF, Wilson J, Pearce C et al. (2016). Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 16(2): 164-180. https://doi.org/10.1016/j.pan.2015.12.006; PMid:26775768
Zheng Y, Mostamand S. (2023, May 5). Nutrition in children with exocrine pancreatic insufficiency. Front Pediatr. 11: 943649. https://doi.org/10.3389/fped.2023.943649; PMid:37215591 PMCid:PMC10196508
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
